Barclays bank says CEO has cancer, to remain in post / Photo: © AFP
-
Make-A-Wish Announces 2026 Starblazer Award Honorees; Allied World Becomes First Corporate Founder
-
Dianna Russini Seeks Super Bowl Radio Row Credential Amid Media Return
-
Lee-Trump Golf Diplomacy Faces Diplomatic Dilemma Ahead of G20 Summit
-
South Africa's Universal Health Coverage Depends on Tackling Poverty and Inequality
-
Mavericks Defeat Jazz 112-100 Behind Washington’s 26 Points and Second-Half Surge
-
Chelsea Transfer News: Real Betis Star Jose Antonio Morante Rejects Move to Stamford Bridge
-
BingX: Major Announcement of Far-Reaching Significance
-
TikTok Security Chief Advises SMBs on Free Cybersecurity Protections
-
James Blunt Scores First Number One Album in 19 Years; Wife Sofia Wellesley Celebrates
-
Egypt Revokes Citizenship of Brothers Anas and Tarek Habib Over Unapproved Foreign Nationality
-
UCLA Stays Unbeaten With Ty Dieffenbach's Heroic Return Against Illinois
-
2027 Rivian R2 Performance vs. 2026 Jeep Recon Moab: EV Comparison Test
Barclays bank says CEO has cancer, to remain in post
British bank Barclays on Monday said its chief executive C.S. Venkatakrishnan is suffering from cancer and will remain in the top post while undergoing treatment.
The lender announced the news in a brief statement alongside a letter by Venkatakrishnan to staff that presented an upbeat prognosis for his non-Hodgkin lymphoma, a cancer affecting the lymph system.
"The good news is that the matter has been detected early, with scans and biopsies confirming it to be very localised," he wrote.
"The doctors have advised that my prognosis is excellent, and my condition is curable with their prescribed regimen."
Venkatakrishnan said his treatment, at Memorial Sloan Kettering Cancer Center in New York, would likely last 12 to 16 weeks.
"During this period, the company will run normally, and I will continue to be actively engaged in managing it," he added.
Barclays last month announced a 10-percent lift in net profit for the third quarter but also revealed rising impairment charges owing to an uncertain economic environment.
O.Lorenz--BTB
